Document is current
Any future updates will be listed below
-
Authors
Bildstein, Tania
Charbit-Henrion, Fabienne https://orcid.org/0000-0003-4615-3953
Azabdaftari, Aline https://orcid.org/0000-0002-1597-0486
Cerf-Bensussan, Nadine https://orcid.org/0000-0003-0665-1245
Uhlig, Holm H. https://orcid.org/0000-0002-6111-7355
- License Information
-
More Information
Article History
Accepted: 28 June 2024
First Online: 8 August 2024
Competing interests
: H.H.U. declares research support or consultancy fees from Janssen, UCB Pharma, Eli Lilly, Bristol Myers Squibb BMS, OMass and Mestag; no stocks or share options. A.A. declares research support from Bristol Myers Squibb. The other authors declare no competing interests.
